Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01334216 · ClinicalTrials.gov registry record · NA
Using Computers to Assist in Parental Smoking Cessation in a Pediatric Setting
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 362
- Enrollment target
NCT01334216: Completed NA study, sponsored by Indiana University.
NCT01334216 is a NA study that has completed, run by Indiana University. The registered enrollment target is 362 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01334216, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 362 participants
- Enrollment target
Study Summary
The CHICA system is a clinical decision support system that uses adaptive turnaround documents to provide point-of-care information to clinicians. The investigators will be studying whether it can help to support parents in their efforts to quit smoking.
Primary Outcome
This is the number of participants who quit smoking
Interventions
- OTHER CHICA Smoking Cessation Module
- OTHER CHICA Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 362 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-06 |
| Phase | NA |
What the finished NCT01334216 record still lists
NCT01334216 is an interventional study that assigns participants to a tested intervention. The registered 362 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which CHICA Smoking Cessation Module is the first listed.
NCT01334216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01334216 about?
NCT01334216 is a clinical study titled "Using Computers to Assist in Parental Smoking Cessation in a Pediatric Setting". The CHICA system is a clinical decision support system that uses adaptive turnaround documents to provide point-of-care information to clinicians. The investigators will be studying whether it can help to support parents in their efforts to quit smoking.
What is the current status of trial NCT01334216?
This trial is currently completed. It is a NA study. The enrollment target is 362 participants. The study started on 2008-07. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01334216?
The interventions under investigation include: CHICA Smoking Cessation Module (OTHER), CHICA Placebo (OTHER).
Who is sponsoring clinical trial NCT01334216?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01334216's enrollment target sits among peer trials
362 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
- NCT06472245 · 363 participants · Phase 3
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia